Immediate Impact
55 standout
Citing Papers
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
2024 Standout
Works of Dan Rudin being referenced
First‐in‐human, randomized dose‐escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF‐06480605 in healthy subjects
2019
Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Dan Rudin | 123 | 186 | 60 | 109 | 25 | 659 | |
| Jing Ma | 108 | 121 | 20 | 274 | 36 | 803 | |
| Julia M. Cruz | 268 | 178 | 18 | 75 | 36 | 742 | |
| Corien Eeltink | 364 | 238 | 40 | 144 | 40 | 819 | |
| W.H. van der Laan | 81 | 91 | 25 | 124 | 28 | 731 | |
| Jonathan R. Korn | 138 | 79 | 26 | 94 | 37 | 834 | |
| Anne Sophie Kubasch | 84 | 238 | 18 | 170 | 35 | 685 | |
| Ibtissam Youlyouz‐Marfak | 157 | 141 | 17 | 132 | 37 | 647 | |
| Alexandra Smith | 55 | 106 | 94 | 157 | 33 | 771 | |
| Zhiqiang Sun | 63 | 77 | 9 | 175 | 30 | 684 | |
| Julia Rey | 346 | 80 | 34 | 41 | 35 | 822 |
All Works
Login with ORCID to disown or claim papers
Loading papers...